OMALIZUMAB

omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe

OMALIZUMAB (11952C)

omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe
11952C
Body System:
Manner of administration:Injection
Private
S100 HSD Private
Authority Required

Restriction

Indication: Uncontrolled severe allergic asthma
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 5 DPMQ: $117.60 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Omlyclo
Xolair